Stem cell comparison: what can we learn clinically from unrelated cord blood transplantation as an alternative stem cell source?

Cytotherapy
Filippo Milano, Jaap Jan Boelens

Abstract

Allogeneic hematopoietic cell transplantation (HCT) is an important therapeutic option for a variety of malignant and non-malignant disorders (NMD). The use of umbilical cord blood transplantation (UCBT) has made HCT available to many more patients. The increased level of human leukocyte antigen disparity that can be tolerated makes UCBT a very attractive alternative source of hematopoietic stem cells; however, the increased risk of early death observed after UCBT remains an obstacle. Novel strategies such as ex vivo stem cell expansion are now becoming part of the standard clinical approach, and preliminary results are extremely encouraging with suggestion of reduction of early transplant-related mortality. Although there are no randomized studies that compare the risks and benefits of UCBT relative to those observed with related and unrelated donors both for malignant and NMD, several retrospective studies have compared outcomes between UCBT and other stem cell sources. In this review, we aim to describe and summarize the findings of the principal studies in this field. We hope that what we can learn from these studies and how we can use this information will improve the outcomes of HCT for patients with malignant and NMD.

References

Jul 18, 1996·The New England Journal of Medicine·J KurtzbergP Rubinstein
Mar 29, 2001·Experimental Hematology·A MorettaF Locatelli
Sep 25, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·A K KleinN J Chao
Nov 27, 2004·The New England Journal of Medicine·Mary J LaughlinMary M Horowitz
Nov 27, 2004·The New England Journal of Medicine·Vanderson RochaUNKNOWN Eurocord-Netcord Registry
Feb 2, 2006·JAMA : the Journal of the American Medical Association·Eyal GrunebaumChaim M Roifman
Jan 1, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul Szabolcs, Donna Niedzwiecki
Apr 16, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mieke AldenhovenTom J de Koning
Dec 2, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Priya KumarLinda J Burns
Feb 11, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kasiani C Myers, Stella M Davies
Apr 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jaap Jan BoelensUNKNOWN EUROCORD, Inborn error Working Party of EBMT and Duke University
Aug 8, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jonathan A GutmanColleen Delaney
Oct 14, 2009·Annals of the Rheumatic Diseases·M AldenhovenN M Wulffraat
Nov 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jon J van RoodAndromachi Scaradavou
Mar 24, 2010·Pediatric Clinics of North America·Jaap J BoelensCharles Peters
Jun 19, 2010·The Lancet Oncology·Mary EapenUNKNOWN National Cord Blood Program of the New York Blood Center
Aug 3, 2010·The Journal of Allergy and Clinical Immunology·Andrew R GenneryUNKNOWN European Society for Immunodeficiency
Dec 8, 2010·British Journal of Haematology·Cécile RénardGérard Michel
Jan 15, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Doris M PonceJuliet N Barker
Apr 7, 2011·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A RuggeriV Rocha
Oct 22, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yi-Bin ChenVincent T Ho
Feb 7, 2012·Blood·Juliana F FernandesUNKNOWN Eurocord and Inborn Errors Working Party of European Group for Blood and Marrow Transplantation
Dec 14, 2012·The New England Journal of Medicine·Marcos de LimaElizabeth J Shpall
Feb 19, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Doris M PonceJuliet N Barker
Mar 16, 2013·Blood·Jaap Jan BoelensUNKNOWN Centre for International Blood and Marrow Research
Aug 13, 2013·Haematologica·Celso Arrais RodriguesUNKNOWN Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Sep 17, 2013·Bone Marrow Transplantation·A MarekUNKNOWN Swiss Blood Stem Cell Transplantation
Jan 21, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Boglarka GyurkoczaHans Joachim Deeg
Jan 28, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marco ZeccaFranco Locatelli
Mar 4, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WeisdorfEliane Gluckman
May 27, 2014·Frontiers in Immunology·Kirsten A ThusEric Spierings
May 29, 2014·Journal of Immunology Research·Kirsten GeneugelijkEric Spierings
Jun 10, 2014·The Journal of Clinical Investigation·Mitchell E HorwitzTony Peled
Jul 31, 2014·British Journal of Haematology·Jaap Jan BoelensRobert F Wynn

❮ Previous
Next ❯

Citations

Sep 22, 2015·Regenerative Medicine·Hengyi ZhangZhiwei Xu
Nov 7, 2018·Journal of Innovation in Health Informatics·Simon Antranik Sarkisian, Andrew Kagel
Mar 11, 2020·Frontiers in Immunology·Valérie JanelleJean-Sébastien Delisle
Nov 25, 2016·Frontiers in Immunology·Mateja Kralj JuricHildegard T Greinix

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.